Thejaswi K. Poonacha, MD, MBA

Articles by Thejaswi K. Poonacha, MD, MBA

Female Representation in Clinical Practice Guideline Panels in 2 Major Cancer Organizations

ByMadhuri Chengappa, MBBS,Ronald S. Go, MD,Ariela Marshall, MD,Thejaswi K. Poonacha, MD, MBA

January 19th 2022

Although female representation for National Comprehensive Cancer Network guidelines has increased to at least 50%, participation in guideline panels across all organizations is still less than 30%.

Oncology Peer Review On-The-Go: Examining Evidence Underlying the NCCN Guidelines for Hematologic Malignancies

ByThejaswi K. Poonacha, MD, MBA,Matthew Fowler

August 3rd 2021

On this CancerNetwork® podcast, we examine the scientific evidence behind the National Comprehensive Cancer Network guidelines for hematologic malignancies.

Level of Scientific Evidence Underlying the National Comprehensive Cancer Network Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?

ByMadhuri Chengappa, MBBS,Aakash P. Desai, MBBS, MPH,Ronald S. Go, MD,Thejaswi K. Poonacha, MD, MBA

July 16th 2021

The level of scientific evidence in National Comprehensive Cancer Network guidelines for malignant hematological conditions haven’t been recently investigated. Herein, investigators describe the distribution of categories of evidence and consensus among the 10 most common hematologic malignancies with regard to recommendations for staging, initial and salvage therapy, and surveillance.